期刊文献+

GRACE风险评分联合B型利钠肽对急性冠脉综合征近期死亡风险的预测价值 被引量:13

Study on value of GRACE risk score and B-type natriuretic peptide as a predictor of prognosis of early mortality in patients with acute coronary syndrome
在线阅读 下载PDF
导出
摘要 目的评价全球急性冠状动脉事件注册(GRACE)风险评分联合B型利钠肽(BNP)对急性冠脉综合征(ACS)患者近期病死率的影响。方法 318例ACS患者测定血浆BNP水平及接受标准GRACE风险评分评定。随访观察入院时血浆BNP和GRACE风险评分对其近期病死率的影响。结果 318例患者近期病死率与高GRACE危险积分相关(P<0.001)。与存活者相比,死亡者GRACE风险总积分最高,且血浆BNP水平亦明显升高。Cox模型分析表明,血浆BNP水平升高和GRACE危险积分均为预测其近期死亡风险升高的独立可靠指标。Kapian-Meier生存曲线分析进一步提示,BNP低于中位数者较高于中位数者近期预后明显较佳(P<0.001)。GRACE风险评价低危组较中、高危组近期预后明显较佳(P<0.01)。近期生存曲线下面积(AUC)BNP为0.886(P<0.001),GRACE危险积分为0.858(P<0.001),而联合BNP水平与GRACE危险积分两者进行综合评定时,AUC为0.937(P<0.001)。结论 ACS发病24 h内早期测定BNP水平联合GRACE危险积分评定可提高其对ACS的预测价值。 Objective To determine whether B-type natriuretic peptide levels and GRACE risk scores can predict early mortality in the patients with acute coronary syndrome(ACS).Methods 318 patients with ACS were studied.Blood was drawn within 24 h after the onset of chest pain and the plasma concentration of BNP was determined and the patients ′ GRACE risk score was measured.To observe the effect of early mortality by BNP levels and GRACE risk score.Results The mortality was 13.5%(n=43) and was related to higher GRACE risk scores(P0.001).Higher BNP levels were also related to mortality in the first 24 h(BNP,2.286[95%CI,1.425-3.667],P=0.001;and GRACE risk scores(1.007[95%CI,1.003-1.011],P=0.001).BNP yielded an mortality.In a multivariate Cox proportional hazards model,independent predictors of BNP and GRACE risk scores,area under the curve(AUC)of 0.886(P0.001),for TIMI risk score the AUC was 0.858(P0.001),for the AUC of combination of TIMI score and BNP was 0.937(P0.001).The receiver-operating curve for the GRACE risk score was complemented by BNP levels for prediction of 30 d mortality.Conclusion In the first 24 h following an ACS,BNP is better than the GRACE risk score at predicting early mortality.The combination of GRACE score and BNP can improve risk prediction for early mortality.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第14期1424-1426,共3页 Chongqing medicine
关键词 利钠肽 B型 死亡率 GRACE危险积分 急性冠脉综合征 natriuretic peptide B-type mortality GRACE risk score acute coronary syndrome
  • 相关文献

参考文献14

  • 1Antman EM,Cohen M,Bernink PJ,et al.The TIMI risk score for unstable angina/non-ST elevation MI:a method for prognostication and therapeutic decision making[J].JAMA,2000,284(7):835-842.
  • 2Boersma E,Pieper KS,Steyerberg EW,et al.Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation.Results from an international trial of 9 461 patients.The PURSUIT Investigators[J].Circulation,2000,101(6):2557-2567.
  • 3Granger CB,Goldberg RJ,Dabbous O,et al.Global Registry of Acute Coronary Events Investigators.Predictors of hospital mortality in the global registry of acute coronary events[J].Arch Intern Med,2003,163(19):2345-2353.
  • 4Squire IB,O′Brien RJ,Demme B,et al.N-terminal pro-atrial natriuretic peptide(NANP)and N-terminal pro-B-type natriuretic peptide(N-BNP)in the prediction of death and heart failure in unselected patients following acute myocardial infarction[J].Clin Sci,2004,107(3):309-316.
  • 5赵睿,杨蕊,杜建霖,邓松柏,王喜春,夏爽,佘强.B型利钠肽联合TIMI危险积分对STEMI患者远期死亡风险预警价值的研究[J].重庆医科大学学报,2010,35(4):538-541. 被引量:4
  • 6高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725. 被引量:5093
  • 7柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2165
  • 8世界卫生组织、北京协和医院.ICD-10疾病和有关健康问题的国际统计分类[M].10版.北京:人民卫生出版社,2007:7.
  • 9叶少武,陆兆华,彭晓燕,卢谦,黎志革,邓春梅.直接经皮冠状动脉介入治疗高龄急性ST段抬高性心肌梗死55例疗效分析[J].重庆医学,2010,39(16):2209-2211. 被引量:8
  • 10Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332(6195):78-81.

二级参考文献56

  • 1羊镇宇,王如兴,李肖蓉,刘志华.B型利钠肽测定对充血性心力衰竭患者预后评估的研究[J].中国心血管杂志,2005,10(3):201-203. 被引量:5
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 3杨起鹏.单硝酸异山梨酯治疗慢性充血性心力衰竭的临床观察[J].实用医学杂志,2007,23(13):2081-2082. 被引量:24
  • 4Tamura N, Ogawa Y, Yasoda A, et al. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J Mol Cell Cardiol,1996,28:1 811.
  • 5Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis, 2002,44(4):293.
  • 6Shapiro BP, Chen HH,Burnett JC , et al. Use of plasma brain natriureticpep tide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc, 2003, 7(8): 4 812-4 816.
  • 7Krishnaswamy P,Lubien E,Clopton P, et al.Utility of B-natriureic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction.Am J Med,2001,111 274-279.
  • 8Catuzzo B,Ciancamerla F,Bobbio M,et al. In patients with severesystolic dysfunction,only brain natriuretic peptide is related todiastolic restrictive patern . J Card Fail ,2003,9 (4): 303- 310.
  • 9Mair J,Lercher AH,Puschendort B.The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.Clin Chem Lab Med,2001,3(9):5 712-5 718.
  • 10Cheng VL , Krishnaswamy P , Kazanegra R , et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Clin Cardial ,2001,3(7):386-391.

共引文献7180

同被引文献86

引证文献13

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部